An announcement from Anbio Biotechnology Class A ( ($NNNN) ) is now available. On December 30, 2025, Anbio Biotechnology reported unaudited ...

Genentech, a San Francisco-based biotech company, has decided to more than double its investment in a new drug manufacturing ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

This real estate investment trust develops and operates life science campuses for leading biotech and technology tenants in ...

(RTTNews) - Insilico Medicine (3696.HK) has listed on the Hong Kong Stock Exchange, marking the latest biotech IPO in Hong Kong this year and becoming the first AI-driven biotech to go public on the ...

Positive interim safety results from the first two dose escalation cohorts, referred to as Cohorts 1 and 2, were reported in 4Q 2024. Today’s update is focused on safety and molecular findings from ...

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the promising stocks to buy under $50. On January 8, Morgan Stanley ...

InduPro, Inc., a biotechnology company defining membrane protein spatial relationships to create novel therapeutics for the ...

Biologist Eduard Batlle used to spend his weekends at his parents’ confectionery. Now he’s one of the six inventors of ...

DelveInsight's Persistent Corneal Edema Market Insights report includes a comprehensive understanding of current treatment ...

The Regeneron Science Talent Search Honors America’s Brightest Young Scientists Advancing Discovery and Innovation ...